Basis of Allotment

New Page 2

(This is only an advertisement for information purposes and not a prospectus announcement)

HPC BIOSCIENCES LIMITED

Our Company was originally incorporated in New Delhi as "HPC Biosciences Limited" on 29th January, 2002 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, National Capital Territory of Delhi & Haryana. For further, please refer to the section titled "Our History and Corporate Structure" beginning on page 77 of this Prospectus.

Registered Office & Corporate Office: 6A, 40, Hanuman Road, Connaught Place, New Delhi-110001;
Tel: 91-11-32965576, Fax: 91-11-32965576 E-Mail: hpcbiosci@yahoo.com; Website: www.hpcbiosciences.com Contact Person & Compliance Officer: Mr. Avinash Kumar Singh, Company Secretary & Compliance Officer;

PROMOTERS OF THE COMPANY: MS. MADHU ANAND & MR. TARUN CHAUHAN

BASIS OF ALLOTMENT

PUBLIC ISSUE OF 45,00,000 EQUITY SHARES OF RS. 10/- EACH ("EQUITY SHARES") OF HPC BIOSCIENCES LIMITED ("HPCBL" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RS. 35/- PER SHARE (THE "ISSUE PRICE"), AGGREGATING TO RS. 1575.00 LACS ("THE ISSUE"), OF WHICH, 2,32,000 EQUITY SHARES OF RS. 10 EACH WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKERS TO THE ISSUE (THE ' MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION I.e. ISSUE OF 42,68,000 EQUITY SHARES OF RS. 10 EACH IS HEREINAFTER REFERRED TO AS THE "NET ISSUE". THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 28.30% AND 26.84%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF THE COMPANY.

In terms of Prospectus dated 22nd February, 2013 and as per Regulation 43 (4) of SEBI (ICDR) Regulations, 2009 wherein a minimum of 50 % of the Net Offer to Public shall be initially made available to Retail Individual Investors as the case may be. The balance net offer of shares to the public shall be made available for allotment to a) individual applicants other than retail investors and b) other investors including corporate bodies / institutions irrespective of no. of shares applied for. The unsubscribed portion of the net offer to any one of the categories specified in (a) or (b) shall/may be made available for allocation in any other category, if so required.

Explanation: for the purpose of Regulation 43 (4) of SEBI (ICDR) Regulations, 2009, if the retail individual investor is entitled to more than fifty percent, on proportionate basis, the retail individual investors shall be allocated that higher percentage.

THE FACE VALUE OF THE EQUITY SHARES IS RS. 10/- EACH AND THE ISSUE PRICE IS RS. 35 EACH. THE ISSUE PRICE IS 3.5 (THREE & HALF) TIMES OF THE FACE VALUE. ISSUE OPENED ON 1ST MARCH, 2013 AND CLOSED ON 5TH MARCH, 2013.

The Equity Shares offered through the Prospectus are proposed to be listed on the SME platform of BSE Limited ("BSE") in terms of the chapter XB of the SEBI (ICDR) Regulations, 2009 as amended from time to time, Company is not required to obtain an in-principle approval of the shares being offered in this Issue. However Company has received an approval letter dated 21 st February, 2013 from BSE for using its name in the offer document for listing of our Shares on the SME platform of BSE. The designated stock exchange is BSE Limited.

All Applicants were allowed to participate in the Issue through APPLICATION SUPPORTED BY BLOCKED AMOUNT ("ASBA") process by providing the details of the respective bank accounts in which the corresponding application amounts were blocked by Self Certified Syndicate Banks (the "SCSBs").

SUBSCRIPTION DETAILS

The Issue has received 574 applications for 49,04,000 Equity Shares (Including Market Maker Application of 2,32,000 Equity Shares) resulting 1.09 times subscription. After considering, cheque return cases of 11 applications of 44,000 Equity Shares, the Issue was subscribed 1.08 times. The details of the applications received in the Issue (before technical rejections) are as follows:

Detail of the Applications Received (Before Technical Rejection & withdrawal of application):

CATEGORY NUMBER OF APPLICATIONS NUMBER OF EQUITY SHARES SUBSCRIPTION
Market Makers 1 232000 1.00
Other than Retail Individual Investor's 118 2862000 1.34
Retail Individual Investor's 444 1776000 0.83
TOTAL 583 4860000 1.08

The details of applications rejected by the Registrar on technical grounds (Including withdrawals) are detailed below:

CATEGORY NUMBER OF APPLICATIONS NUMBER OF EQUITY SHARES
Market Makers Nil Nil
Other than Retail Individual Investor's 5 184000
Retail Individual Investor's 18 72000
TOTAL 23 256000

Detail of the Applications Received (After Technical Rejection & withdrawal):

CATEGORY NUMBER OF APPLICATIONS NUMBER OF EQUITY SHARES SUBSCRIPTION
Market Makers 1 232000 1.00
Other than Retail Individual Investor's 113 2668000 1.25
Retail Individual Investor's 428 1704000 0.80
TOTAL 540 4804000 1.02

ALLOCATION: The Basis of Allotment was finalized In consultation with the Designated Stock Exchange - BSE Limited on 14th March, 2013.

A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the Issue price of Rs. 35/- per Equity Share, was finalised in consultation with BSE. The category was subscribed by 1.00 times. The total number of shares allotted In this category Is 2,32,000 Equity shares In full out of reserved portion of 2,32,000 Equity Shares.

B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Retail Individual Investors, at the Issue price of Rs. 35/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 0.80 times. Total number of shares allotted In this category Is 17,04,000 Equity Shares against reservation of 21,34,000 Shares. The balance 4,30,000 Shares has been added to Non Institutional category as spill over. The category wise basis of allotment Is as under.

No. of Shares Applied for (Category wise) No. Of Applications % to total Total No. of Equity Shares applied % of total Proportionate Shares Available Allocation per Applicant Ratio of Allottee To The Applicants Total No. of Equity Shares allotted Surplus/ (Deficit)
4000 426 100 1704000 100 2134000 4000 FIRM 1704000 (430000)
TOTAL 426 100 1704000 100 2134000 4000 - 1704000 (430000)

C. Allocation to Non Retail Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the issue price of Rs. 35/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 1.25 times. Total number of shares allotted In this category is 26,24,000 Equity Shares including spill over of 4,30,000 Shares from retail individual Investors category and additional 60,000 Equity Shares for the purpose of rounding off to the nearest multiple of 4,000 Equity Shares (Lot Size). The category wise basis of allotment is as under:

No. of Shares Applied for (Category wise) No. Of Applications % to total Total No. of Equity Shares applied % of total Proportionate Shares Available Allocation per Applicant (Before Rounding Off) Allocation per Applicant (After Rounding Off) Ratio of AlotteesTo The Applicants Total No. of Equity Shares allotted Surplus/ (Deficit)
8000 35 30.97 280000 10.49 269085.46 7688.16 8000 FIRM 280000 10914.54
12000 12 10.62 144000 5.40 138386.81 11532.23 12000 FIRM 144000 5613.19
16000 12 10.62 192000 7.20 184515.74 15376.31 16000 FIRM 192000 7484.26
20000 23 24.78 560000 20.99 538170.91 19220.39 20000 FIRM 560000 21829.09
24000 1 0.88 24000 0.90 23064.47 23064.47 24000 FIRM 24000 935.53
28000 9 7.96 252000 9.45 242176.91 26908.55 28000 FIRM 252000 9823.09
32000 4 3.54 128000 4.80 123010.49 30752.62 32000 FIRM 128000 4989.51
40000 3 2.65 120000 4.50 115322.34 38440.78 40000 FIRM 120000 4677.66
48000 1 0.88 48000 1.80 46128.94 46128.94 48000 FIRM 48000 1871.06
60000 2 1.77 120000 4.50 115322.34 57661.17 56000 FIRM 112000 (3322.34)
100000 2 1.77 200000 7.50 192203.90 96101.95 96000 FIRM 192000 (203.90)
120000 1 0.88 120000 4.50 115322.34 115322.34 116000 FIRM 116000 677.66
160000 3 2.65 480000 17.99 461289.36 153763.12 152000 FIRM 456000 (5289.36)
TOTAL 113 100 2668000 100 2564000 2624000 60000

The Board of Directors of the Company at its meeting held on 14th March, 2013 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. BSE and has authorized the corporate action for the transfer of the Equity Shares / dispatch of share certificates to various successful applicants.

The CAN-cum-Refund Orders and allotment advice and/or notices are being dispatched to the address of the Applicants as registered with the depositories / as filled in the application form on or before 16th March, 2013. Further, the instructions to Self Certified Syndicate Banks being processed on or prior to 16th March, 2013. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the SME Platform of BSE Limited within Twelve working days from the date of the closure of the Issue.The trading is proposed to be commenced on or before 19th March, 2013 subject to receipt of listing and trading approvals from BSE Limited.

INVESTORS PLEASE NOTE

The details of the allotment made would also be hosted on the website of the Registrar to the Issue, Cameo Corporate Services Limited at www.cameoindia.com. All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:

CAMEO CORPORATE SERVICES LTD.

Subramanian Building, 1 Club House Road,
Chennai 600002.
Tel No.: +91-44-2846 0390(5 Lines)
Fax No.:+91-44-2846 0129
Website: www.cameoindia.com
E-mail ID: investor@cameoindia.com

For HPC Biosciences Limited
Sd/-
Avinash Kumar Singh
Company Secretary

Place : New Delhi
Date  : 14.03.2013

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF HPC BIOSCIENCES LIMITED.
Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus.

Close